New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

PPAR Res 2009 29;2009:571365. Epub 2009 Jun 29.

Department of Clinical and Experimental Medicine "G. Salvatore", University of Catanzaro "Magna Graecia", V.le Europa (Loc. Germaneto), 88100 Catanzaro, Italy.

The insulin receptor (IR) plays a crucial role in mediating the metabolic and proliferative functions triggered by the peptide hormone insulin. There is considerable evidence that abnormalities in both IR expression and function may account for malignant transformation and tumour progression in some human neoplasias, including breast cancer. PPARγ is a ligand-activated, nuclear hormone receptor implicated in many pleiotropic biological functions related to cell survival and proliferation. In the last decade, PPARγ agonists-besides their known action and clinical use as insulin sensitizers-have proved to display a wide range of antineoplastic effects in cells and tissues expressing PPARγ, leading to intensive preclinical research in oncology. PPARγ and activators affect tumours by different mechanisms, involving cell proliferation and differentiation, apoptosis, antiinflammatory, and antiangiogenic effects. We recently provided evidence that PPARγ and agonists inhibit IR by non canonical, DNA-independent mechanisms affecting IR gene transcription. We conclude that IR may be considered a new PPARγ "target" gene, supporting a potential use of PPARγ agonists as antiproliferative agents in selected neoplastic tissues that overexpress the IR.

Download full-text PDF

Source
http://dx.doi.org/10.1155/2009/571365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705764PMC
September 2012
4 Reads

Publication Analysis

Top Keywords

insulin receptor
8
pparγ
8
pparγ agonists
8
proved display
4
sensitizers-have proved
4
antineoplastic effects
4
range antineoplastic
4
effects cells
4
wide range
4
display wide
4
tissues expressing
4
preclinical oncology
4
oncology pparγ
4
pparγ activators
4
intensive preclinical
4
leading intensive
4
expressing pparγ
4
pparγ leading
4
cells tissues
4
insulin sensitizers-have
4

References

(Supplied by CrossRef)

Endocrine Reviews 1987

Nature 1985

The Journal of Biological Chemistry 1994

Diabetes 1989

The Journal of Biological Chemistry 1987

Proceedings of the National Academy of Sciences of the United States of America 1989

Journal of Clinical Investigation 1993

Nature Reviews Cancer 2001

Similar Publications